May 14 |
What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock
|
May 14 |
Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet
|
May 9 |
Lexeo Therapeutics reports Q1 results
|
May 9 |
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
|
May 7 |
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
|
Apr 29 |
IPO Roundup: Viking Holdings, RanMarine Technology, and more
|
Apr 22 |
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
|
Apr 22 |
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
|
Apr 16 |
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
|
Apr 9 |
Lexeo: Targeted Alzheimer's Disease Treatment Approach Might Pay Off
|